The themes Materialise is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
売上構成比はFY2025の推計であり、提出された報告書の数字ではありません。
Magics
Software that prepares 3D models for printing, including repairing designs, arranging parts for a print run and planning printer instructions.
CO-AM
Software that helps manufacturers manage 3D-printing work, from orders and quotes to production schedules, quality checks and machine connections.
Materialise Mimics
Medical software that turns scan data into 3D anatomical models for research, treatment planning and the design of personalized medical devices.
Materialise OrthoView
Software that lets orthopedic surgeons plan procedures by placing digital implant templates on X-ray images.
Patient-specific surgical guides and implants
Devices designed for an individual patient and printed to help surgeons carry out a planned procedure.
Industrial 3D printing services
Printed prototypes and production parts for industries including aerospace, automotive, medical technology and semiconductors.
Materialise develops software for preparing three-dimensional (3D) printing jobs and analyzing medical scans, and runs printing facilities that make industrial parts and patient-specific surgical guides, models and implants. Its medical software helps clinicians turn computed tomography (CT) and magnetic resonance imaging (MRI) scans into 3D anatomy for treatment planning; its factory software helps manufacturers prepare files, plan production and coordinate printers. It earns money from software licenses and support, engineering services, printed medical devices and industrial production services.
Materialise NV 自身が米国証券取引委員会(SEC)に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 この企業は EUR で開示しています。数字は現在のレート $1.00 = 0.902450 EUR で米ドルに換算し、すべての期間に同じレートを適用しています——したがって成長率や利益率は企業自身のものであり、為替のものではありません。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
$6.59-5.7%11月12日 終値
2026年9月30日までの数値(2026年10月29日提出の6-Kより)
Materialise sells medical planning software and custom surgical guides and implants to hospitals and medical-device companies, plus 3D-printed parts to manufacturers.
Grade A
株価の下の帯は各日付時点の評価で、その時点までに公開された書類だけで算出しています。
Materialise NV の評価履歴 29 四半期のうち 2 四半期を表示しています。 残る 27 四半期は 2018年5月 まで遡ります。